Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

The primary treatment for women with endometrial cancer (EC) is abdominal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy, followed by adjuvant radiotherapy depending on clinicopathological risk factors. Currently, four risk groups of EC have been defined: low, intermediate, high-intermediate (HIR) and high-risk.[1]

Source: Radiotherapy and Oncology - November 4, 2020 Category: Radiology Authors: B.G. Wortman, E. Astreinidou, M.S. Laman, E.M. van der Steen-Banasik, L.C.H.W. Lutgens, H. Westerveld, F. Koppe, A. Slot, H.A. van den Berg, M.E. Nowee, S. Bijmolt, T.C. Stam, A.G. Zwanenburg, J.W.M. Mens, I.M. J ürgenliemk-Schulz, A. Snyers, C.M. Gillha Tags: Original Article Source Type: research